Drug intelligence / Profile preview

Streptococcus salivarius K12

Development stage
Phase 2
Lead developer
BLIS Technologies
Modality
Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Streptococcus salivarius K12 is an oral probiotic strain isolated from the saliva of a healthy New Zealand child in 1989. It produces two lantibiotics (salivaricin A2 and salivaricin B) that antagonize the growth of Streptococcus pyogenes and other bacterial pathogens. The probiotic is used to prevent recurrent streptococcal and viral infections, reduce oral mucositis, inhibit volatile sulfur compounds associated with halitosis, and improve oral health.

Brand names
BLIS K12Bactoblis
Other names
Streptococcus salivarius K-12

Beyond the preview

Go deeper on Streptococcus salivarius K12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus salivarius K12.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call